0000899243-19-030008.txt : 20191223 0000899243-19-030008.hdr.sgml : 20191223 20191223191105 ACCESSION NUMBER: 0000899243-19-030008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191219 FILED AS OF DATE: 20191223 DATE AS OF CHANGE: 20191223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mulholland Michael D. CENTRAL INDEX KEY: 0001257911 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 191307712 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER NAME: FORMER CONFORMED NAME: MULHOLLAND MICHAEL D DATE OF NAME CHANGE: 20030801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-19 0 0001175680 CytoDyn Inc. CYDY 0001257911 Mulholland Michael D. 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 0 1 0 0 See Remarks Stock Option (right to buy) 0.63 2019-12-19 4 A 0 700000 0.00 A 2029-12-19 Common Stock 700000 700000 D One-half of the options vest immediately upon grant and one-half of the options will vest upon the achievement of certain additional strategic milestones specified in the award agreement. Senior Vice President of Finance /s/ Michael D. Mulholland, as attorney-in-fact 2019-12-23